Press release
Insights on the Flu RNA Vaccines Market Report & Forecast to 2028 - by Players, Types, Applications and Region
QY Research latest released a report about Flu RNA Vaccines. This report focuses on global and United States Flu RNA Vaccines, also covers the segmentation data of other regions in regional level and county level.Key Market Segmentation
Flu RNA Vaccines is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Flu RNA Vaccines will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Flu RNA Vaccines size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
For more information about this report, visit
https://us.qyresearch.com/reports/355758/flu-rna-vaccines
Breakup by Type
Non-Replicating mRNA
In Vivo Self-Replicating mRNA
In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
Others
Breakup by Application
Hospitals
Vaccination Center
Specialized Clinics
Hospital Pharmacy
Others
Breakup by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Breakup by Company
Sanofi Pasteur Inc.
AstraZeneca
CSL Ltd.
Abbott
GlaxoSmithKline Plc.
Serum Institute of India Pvt. Ltd.
Pfizer
BioNTech
F.Hoffman La Roche Ltd
Novartis
Sinnovac Biotech Ltd
Moderna Therapeutics
CureVac
Key Questions Answered in This Report
How has the Global and United States Flu RNA Vaccines performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the Flu RNA Vaccines type?
What is the breakup of the market based on the application?
What is the breakup of the market size based on the region?
What is the breakup of the market based on the region Level & country Level?
What is the structure of the Global and United States Flu RNA Vaccines and who are the key players?
Key Topics Covered:
1 Study Coverage
1.1 Flu RNA Vaccines Product Introduction
1.2 Global Flu RNA Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Flu RNA Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Flu RNA Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Flu RNA Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Flu RNA Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Flu RNA Vaccines Sales in Volume for the Year 2017-2028
1.4 Flu RNA Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Flu RNA Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Flu RNA Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Flu RNA Vaccines Market Dynamics
1.5.1 Flu RNA Vaccines Industry Trends
1.5.2 Flu RNA Vaccines Market Drivers
1.5.3 Flu RNA Vaccines Market Challenges
1.5.4 Flu RNA Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Flu RNA Vaccines Market Segment by Type
2.1.1 Non-Replicating mRNA
2.1.2 In Vivo Self-Replicating mRNA
2.1.3 In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
2.1.4 Others
2.2 Global Flu RNA Vaccines Market Size by Type
2.2.1 Global Flu RNA Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Flu RNA Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Flu RNA Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Flu RNA Vaccines Market Size by Type
2.3.1 United States Flu RNA Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Flu RNA Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Flu RNA Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Flu RNA Vaccines Market Segment by Application
3.1.1 Hospitals
3.1.2 Vaccination Center
3.1.3 Specialized Clinics
3.1.4 Hospital Pharmacy
3.1.5 Others
3.2 Global Flu RNA Vaccines Market Size by Application
3.2.1 Global Flu RNA Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Flu RNA Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Flu RNA Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Flu RNA Vaccines Market Size by Application
3.3.1 United States Flu RNA Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Flu RNA Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Flu RNA Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Flu RNA Vaccines Competitor Landscape by Company
4.1 Global Flu RNA Vaccines Market Size by Company
4.1.1 Top Global Flu RNA Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Flu RNA Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Flu RNA Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Flu RNA Vaccines Price by Manufacturer (2017-2022)
4.2 Global Flu RNA Vaccines Concentration Ratio (CR)
4.2.1 Flu RNA Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Flu RNA Vaccines in 2021
4.2.3 Global Flu RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Flu RNA Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Flu RNA Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Flu RNA Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Flu RNA Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Flu RNA Vaccines Market Size by Company
4.5.1 Top Flu RNA Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Flu RNA Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Flu RNA Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Flu RNA Vaccines Market Size by Region
5.1 Global Flu RNA Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Flu RNA Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Flu RNA Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Flu RNA Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Flu RNA Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Flu RNA Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Flu RNA Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Flu RNA Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Flu RNA Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Flu RNA Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Flu RNA Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Flu RNA Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Flu RNA Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Flu RNA Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Flu RNA Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Flu RNA Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Flu RNA Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi Pasteur Inc.
7.1.1 Sanofi Pasteur Inc. Corporation Information
7.1.2 Sanofi Pasteur Inc. Description and Business Overview
7.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Pasteur Inc. Flu RNA Vaccines Products Offered
7.1.5 Sanofi Pasteur Inc. Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Corporation Information
7.2.2 AstraZeneca Description and Business Overview
7.2.3 AstraZeneca Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 AstraZeneca Flu RNA Vaccines Products Offered
7.2.5 AstraZeneca Recent Development
7.3 CSL Ltd.
7.3.1 CSL Ltd. Corporation Information
7.3.2 CSL Ltd. Description and Business Overview
7.3.3 CSL Ltd. Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 CSL Ltd. Flu RNA Vaccines Products Offered
7.3.5 CSL Ltd. Recent Development
7.4 Abbott
7.4.1 Abbott Corporation Information
7.4.2 Abbott Description and Business Overview
7.4.3 Abbott Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Abbott Flu RNA Vaccines Products Offered
7.4.5 Abbott Recent Development
7.5 GlaxoSmithKline Plc.
7.5.1 GlaxoSmithKline Plc. Corporation Information
7.5.2 GlaxoSmithKline Plc. Description and Business Overview
7.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GlaxoSmithKline Plc. Flu RNA Vaccines Products Offered
7.5.5 GlaxoSmithKline Plc. Recent Development
7.6 Serum Institute of India Pvt. Ltd.
7.6.1 Serum Institute of India Pvt. Ltd. Corporation Information
7.6.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
7.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Products Offered
7.6.5 Serum Institute of India Pvt. Ltd. Recent Development
7.7 Pfizer
7.7.1 Pfizer Corporation Information
7.7.2 Pfizer Description and Business Overview
7.7.3 Pfizer Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Pfizer Flu RNA Vaccines Products Offered
7.7.5 Pfizer Recent Development
7.8 BioNTech
7.8.1 BioNTech Corporation Information
7.8.2 BioNTech Description and Business Overview
7.8.3 BioNTech Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 BioNTech Flu RNA Vaccines Products Offered
7.8.5 BioNTech Recent Development
7.9 F.Hoffman La Roche Ltd
7.9.1 F.Hoffman La Roche Ltd Corporation Information
7.9.2 F.Hoffman La Roche Ltd Description and Business Overview
7.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 F.Hoffman La Roche Ltd Flu RNA Vaccines Products Offered
7.9.5 F.Hoffman La Roche Ltd Recent Development
7.10 Novartis
7.10.1 Novartis Corporation Information
7.10.2 Novartis Description and Business Overview
7.10.3 Novartis Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Novartis Flu RNA Vaccines Products Offered
7.10.5 Novartis Recent Development
7.11 Sinnovac Biotech Ltd
7.11.1 Sinnovac Biotech Ltd Corporation Information
7.11.2 Sinnovac Biotech Ltd Description and Business Overview
7.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sinnovac Biotech Ltd Flu RNA Vaccines Products Offered
7.11.5 Sinnovac Biotech Ltd Recent Development
7.12 Moderna Therapeutics
7.12.1 Moderna Therapeutics Corporation Information
7.12.2 Moderna Therapeutics Description and Business Overview
7.12.3 Moderna Therapeutics Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Moderna Therapeutics Products Offered
7.12.5 Moderna Therapeutics Recent Development
7.13 CureVac
7.13.1 CureVac Corporation Information
7.13.2 CureVac Description and Business Overview
7.13.3 CureVac Flu RNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 CureVac Products Offered
7.13.5 CureVac Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Flu RNA Vaccines Industry Chain Analysis
8.2 Flu RNA Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Flu RNA Vaccines Distributors
8.3 Flu RNA Vaccines Production Mode & Process
8.4 Flu RNA Vaccines Sales and Marketing
8.4.1 Flu RNA Vaccines Sales Channels
8.4.2 Flu RNA Vaccines Distributors
8.5 Flu RNA Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Receive Free Sample, Charts, Tables or Full Report, Please enter:
https://us.qyresearch.com/reports/355758/flu-rna-vaccines
Any questions or requirements, please do not hesitate to contact us.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
QY Research latest released a report about Flu RNA Vaccines. This report focuses on global and United States Flu RNA Vaccines, also covers the segmentation data of other regions in regional level and county level.
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights on the Flu RNA Vaccines Market Report & Forecast to 2028 - by Players, Types, Applications and Region here
News-ID: 2635200 • Views: …
More Releases from QY Research
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
Global and U.S. Loose Bulk Density Meters Market Report, Published by QY Researc …
Loose Bulk Density Meters are specialized instruments used to measure the mass per unit volume of bulk powders and granular materials in an uncompacted state. These devices help determine flowability, packing behavior, and quality control parameters critical in industries such as pharmaceuticals, chemicals, food processing, and construction materials. Measurement methods typically involve automated funnels, weighing platforms, and volume displacement chambers to ensure reproducibility.
https://www.qyresearch.com/reports/4937970/loose-bulk-density-meters
The global Loose Bulk Density Meters market reached…
Global and U.S. Interactive Visual Presenters Market Report, Published by QY Res …
Interactive Visual Presenters, also known as document cameras or digital visualizers, are teaching and presentation tools that project real-time images of documents, 3D objects, or live demonstrations onto large displays through HDMI, USB, or wireless interfaces. Equipped with high-resolution cameras, LED lighting, zoom, and annotation functions, they are widely used in classrooms, corporate training, and hybrid learning environments.
https://www.qyresearch.com/reports/4941119/interactive-visual-presenters
The global Interactive Visual Presenters market reached USD 584 million in 2024, growing…
Commercial Three Phase Micro Inverter Market to CAGR 12,4% by 2031 Top 10 Compan …
The global commercial three phase micro inverter market is witnessing accelerated adoption as industries and commercial establishments embrace renewable energy solutions for cost efficiency, grid stability, and sustainability. Micro inverters, which convert direct current (DC) from solar panels into alternating current (AC) at the individual panel level, are increasingly being used in commercial three phase setups for enhanced efficiency, safety, and scalability. Unlike string inverters, three phase micro inverters offer…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
